Merrimack Pharmaceuticals Inc
Company Overview
Merrimack Pharmaceuticals Inc. is a biopharmaceutical company that was primarily focused on developing innovative medicines for cancer treatment. The company has undergone significant changes and currently operates as a holding company that is entitled to receive milestone payments and royalties from previously-sold products, particularly from the development and commercialization of ONIVYDE®, which was sold to Ipsen S.A.
The company no longer conducts active research and development operations and its primary focus is on managing its milestone payment and royalty rights from previous arrangements.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Merrimack Pharmaceuticals Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.